Trial Profile
Clinical Trials Insight: 700033646
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 16 May 2008
Price :
$35
*
At a glance
- Drugs DSP 3025 (Primary)
- Indications Hypersensitivity
- Focus Adverse reactions
- Sponsors Sumitomo Pharma
- 16 May 2008 New trial record.